📈 Jumpstart Signal Watchlist — October 07, 2026

🚀 Growth ($5-$20)

# Ticker Signal Industry Score (100) Q+E+S+B Price Change RSI 3yr High
1 PAYS25 📌 MONITOR Business Services 60 (53+0+7+0) $14.95 +5.1% 68 $14.95
2 OSPN2 📌 MONITOR Computer Integrated Systems ... 57 (39+0+8+10) $17.70 -3.5% 54 $20.23
3 VIR13 📌 MONITOR Biological Products 51 (32+2+7+10) $11.52 +1.8% 59 $12.66
Screening Criteria ↓

⚖️ Momentum ($20-$100)

# Ticker Signal Industry Score (100) Q+E+S+B Price Change RSI 3yr High
1 MGNI11 📌 MONITOR Computer Programming & Data ... 70 🎓 (50+0+10+10) $25.24 +2.1% 57 $26.52
2 CDNA10 📌 MONITOR Medical Laboratories 68 🎓 (59+0+9+0) $63.04 +2.7% 61 $69.85
3 GCT1 📌 MONITOR Catalog & Mail-Order 65 (53+5+7+0) $55.96 +3.9% 65 $55.96
4 DGII6 📌 MONITOR Computer Communications Equi... 64 (44+0+10+10) $75.21 +3.0% 53 $85.24
5 SMCI 📌 MONITOR Electronic Computers 63 (49+0+4+10) $44.94 +5.5% 65 $117.86
Screening Criteria ↓

🏆 SPOTLIGHT   |   ✅ OPPORTUNITY   |   📌 MONITOR

📡 Movers on Our Radar

How much each stock moved from its opening price to its closing price on 2026-10-07, among the stocks that passed our Stage 1 screen. This is not a market-wide list.

🚀 Growth — Analysis

PAYS 📌 MONITOR - Paysign, Inc.
Score: 60/100 (53+0+7+0) Price: $14.95 Chg: +5.1% RSI: 68 Vol: 873K 3yr High: $14.95

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 At/above 3yr high $14.95 (current $14.95) · ⏳ SMA200 $7.46 (current price $14.95 is above) · 💰 Market Cap $844M
- PAYS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 450% (>20%); Revenue growth 48% (>15%); ROE 26% (>15%); Low LT D/E 0.06 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (11.3%)
- 🔔 Strong above EMA50 (20.9%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 68 showing strength
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (✅×1 ⚪️×2).
✅ DA Davidson raises Paysign stock price target to $15 on growth outlook — Investing.com.
🤖 DA Davidson raised its price target from $12 to $15 and maintained a Buy rating. The article also notes Paysign’s second-quarter results exceeded analyst expectations and the company raised its full-year outlook.
⚪️ Paysign EVP, operations Joan Herman sells $716,899 in shares — Investing.com.
🤖 The article reports planned insider share sales under a Rule 10b5-1 trading plan adopted in 2025. This is a disclosure of past transactions, not by itself a new directional catalyst.
⚪️ Paysign chief innovation officer Michael Ngo sells $1.9m in stock — Investing.com.
🤖 The article reports the chief innovation officer’s share sales on September 8 and 9. The transactions are backward-looking insider-sale disclosures and do not establish a new company catalyst.
🍭 Bonus (B): 0/10 — Business Services

OSPN 📌 MONITOR - OneSpan Inc.
Score: 57/100 (39+0+8+10) Price: $17.70 Chg: -3.5% RSI: 54 Vol: 590K 3yr High: $20.23

🏢 What they do: OneSpan provides cybersecurity and digital agreement solutions, including identity verification, authentication, fraud prevention, and mobile app security. Its digital agreement products support secure e-signatures, online notarization, and automated document workflows.
- 🎯 Current $17.70 is 12% below 3yr high $20.23 · ⏳ SMA200 $13.52 (current price $17.70 is above) · 💰 Market Cap $651M
- OSPN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 39/60
- 🏦 Low drawdown (14.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; ROE 25% (>15%); Low LT D/E 0.00 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 54 in healthy mid-range
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×2; showing 4 of 5).
✅ OneSpan Expands OneSpan Sign Beyond eSignature Capabilities to Move Customer-Facing Agreements Forward, Faster and With Greater Confidence — Business Wire.
🤖 OneSpan announced an expansion of its Digital Agreements portfolio beyond eSignature, adding capabilities intended to streamline agreement workflows. The product expansion could strengthen the company’s offering and support future growth.
✅ OneSpan expands digital agreements platform beyond e-signature — Investing.com.
🤖 The article reports new and planned platform features, including AI-assisted document preparation, validation, and biometric identity verification. These enhancements may improve OneSpan’s competitiveness in digital agreements, though their commercial impact is not yet established.
⚪️ OneSpan's (OSPN) Subscription Growth Masks A Shrinking Bottom Line — Yahoo Finance.
🤖 The article describes mixed second-quarter results: subscription revenue and annual recurring revenue grew, and full-year guidance was raised, while operating income declined and cybersecurity revenue fell. The positive growth and guidance signals are offset by weaker profitability and segment performance.
⚪️ OneSpan (OSPN) Dips More Than Broader Market: What You Should Know — Yahoo Finance.
🤖 The article reports a one-day share-price decline but also notes that OneSpan had outperformed the broader market over the preceding month. Its discussion of upcoming earnings expectations is not a new company-specific catalyst, so the price move alone provides limited directional information.
🍭 Bonus (B): 10/10 — Computer Integrated Systems Design (Technology sector)

VIR 📌 MONITOR - Vir Biotechnology, Inc.
Score: 51/100 (32+2+7+10) Price: $11.52 Chg: +1.8% RSI: 59 Vol: 3.6M 3yr High: $12.66

🏢 What they do: Vir Biotechnology is a clinical-stage biopharmaceutical company that develops medicines for serious infectious diseases and cancer. Its work centers on immune-based therapies, including antibody-based and other platform-driven drug candidates such as programs for hepatitis delta, hepatitis B, and solid tumors.
- 🎯 Current $11.52 is 9% below 3yr high $12.66 · ⏳ SMA200 $9.04 (current price $11.52 is above) · 💰 Market Cap $1.9B
- VIR shows decent technicals supported by positive sentiment.

💎 Quality (Q): 32/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 159% (>20%); Low LT D/E 0.00 (<1.0).
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (✅×1 ⚪️×2).
✅ Vir Biotechnology Appoints David Liu as Chief Medical Officer — Business Wire.
🤖 Vir appointed David Liu as executive vice president and chief medical officer, overseeing clinical development, medical affairs, and regulatory affairs. The senior leadership appointment may support execution of the company’s clinical programs.
⚪️ Vir Biotechnology to Present Expanded Phase 2 SOLSTICE Results for Elebsiran and Tobevibart in Hepatitis Delta at AASLD’s The Liver Meeting® 2026 — Yahoo Finance.
🤖 Vir said it plans to present Phase 2 SOLSTICE trial data at a medical meeting in November. The article announces a future presentation but provides no results or new efficacy information, so its direct price impact is unclear.
⚪️ Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer — Business Wire.
🤖 Vir announced Aziz Sawaf’s appointment as executive vice president and CFO, with responsibility for finance, IT, and investor relations. The article reports a leadership change without financial guidance or other direct business developments.
🍭 Bonus (B): 10/10 — Biological Products (Biotech sector)

⚖️ Momentum — Analysis

MGNI 📌 MONITOR - Magnite, Inc.
Score: 70/100 (50+0+10+10) Price: $25.24 Chg: +2.1% RSI: 57 Vol: 2.2M 3yr High: $26.52

🏢 What they do: Magnite is an advertising technology company that provides a sell-side platform for digital advertising. Its software helps publishers and media owners manage and monetize ad inventory across channels like connected TV, video, mobile, and desktop, while also connecting them with advertisers and agencies.
- 🎯 Current $25.24 is 5% below 3yr high $26.52 · ⏳ SMA200 $17.05 (current price $25.24 is above) · 💰 Market Cap $3.6B
- MGNI shows decent technicals supported by positive sentiment.

💎 Quality (Q): 50/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 62% (>20%); ROE 18% (>15%); Low LT D/E 0.37 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ Magnite Successfully Completes Term Loan and Revolving Credit Facility Repricing — Yahoo Finance.
🤖 Magnite reduced the interest rate on its term loan by 50 basis points and lowered the revolving credit facility margin by 100 basis points. The changes are expected to save approximately $1.8 million in annualized cash interest, supporting cash flow.
✅ Magnite (MGNI) Lands HP TV+ Deal But Is The Upside Already Priced In — Yahoo Finance.
🤖 Magnite secured a role as the primary video ad server and programmatic technology provider for HP TV+, adding a customer and distribution opportunity. The article notes the stock had already risen recently, which may temper the near-term upside.
✅ Magnite (NASDAQ:MGNI) Stock Keeps Buy Rating at Rosenblatt Securities — MarketBeat.
🤖 Rosenblatt reiterated its Buy rating and $40 price target, signaling continued analyst confidence. The article also reports B. Riley raised its target to $30 while maintaining a Buy rating.
🍭 Bonus (B): 10/10 — Computer Programming & Data Processing (Technology sector)

CDNA 📌 MONITOR - CareDx, Inc.
Score: 68/100 (59+0+9+0) Price: $63.04 Chg: +2.7% RSI: 61 Vol: 1.7M 3yr High: $69.85

🏢 What they do: CareDx, Inc. is a precision medicine company focused on transplant patients. It develops diagnostics, digital health tools, lab products, and patient support services to help monitor care before and after organ transplantation.
- 🎯 Current $63.04 is 10% below 3yr high $69.85 · ⏳ SMA200 $29.41 (current price $63.04 is above) · 💰 Market Cap $3.2B
- CDNA shows decent technicals supported by positive sentiment.

💎 Quality (Q): 59/60
- 🏦 Low drawdown (12.2% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1394% (>20%); Revenue growth 52% (>15%); ROE 26% (>15%).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (5.3%)
- 🔔 Strong above EMA50 (20.7%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 61 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ CareDx (NASDAQ:CDNA) Hits New 1-Year High — MarketBeat.
🤖 CareDx shares reached a new one-year high. The article also cites BTIG’s September 24 increase in its price target to $74 while maintaining a Buy rating.
✅ CareDx +14% on Fresh $74 Analyst Price Target — Yahoo Finance.
🤖 BTIG raised its price target from $60 to $74 and maintained its Buy rating, accompanying a reported 14% share-price rise. The article also points to transplant-testing growth and the company’s oncology pipeline.
⚪️ CareDx (NASDAQ:CDNA) Shares Down 6.2% - Time to Sell? — MarketBeat.
🤖 The article reports a one-day share-price decline, but its analyst detail notes BTIG’s earlier price-target increase to $74 and maintained Buy rating. The reported price move alone does not establish a company-specific change in outlook.
🍭 Bonus (B): 0/10 — Medical Laboratories

GCT 📌 MONITOR - GigaCloud Technology Inc
Score: 65/100 (53+5+7+0) Price: $55.96 Chg: +3.9% RSI: 65 Vol: 1.0M 3yr High: $55.96

🏢 What they do: GigaCloud Technology Inc. (GCT) operates a B2B e-commerce marketplace specializing in large-parcel merchandise like furniture, appliances, and fitness equipment. It provides an end-to-end platform that connects manufacturers (primarily in Asia) with retailers in markets such as the US and Europe, handling product sourcing, logistics, global fulfillment across 39 facilities, sales, and delivery.
- 🎯 At/above 3yr high $55.96 (current $55.96) · ⏳ SMA200 $42.50 (current price $55.96 is above) · 💰 Market Cap $522M
- GCT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 Base breakout (range: 7.1%); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 27% (>20%); Revenue growth 28% (>15%); ROE 29% (>15%).
⏰ Entry (E): 5/20
- 🔔 Strong above EMA21 (5.8%)
- 🔔 Strong above EMA50 (11.8%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 7/10
- 🗞️ News sentiment is positive (✅×2 ⚪️×3; showing 4 of 5).
✅ GigaCloud Technology Inc stock reaches 52-week high at $56.37 — Investing.com.
🤖 The article reports that GCT reached a 52-week high, reflecting strong recent share-price performance. It also cites the company’s reported second-quarter revenue growth and share buyback plan as recent developments.
✅ GigaCloud Technology (NASDAQ:GCT) Hits New 12-Month High — MarketBeat.
🤖 The article reports GCT reaching a new 12-month high and notes recent analyst rating upgrades alongside a downgrade. The price milestone and upgrades are positive signals, though the rating changes are mixed.
⚪️ GigaCloud Technology (NASDAQ:GCT) Downgraded by Wall Street Zen to Buy — MarketBeat.
🤖 Wall Street Zen lowered its rating from Strong Buy to Buy, while Weiss Ratings upgraded its view from Hold to Buy. The mixed rating changes do not point to a clear directional catalyst.
⚪️ GigaCloud technology director Bernes sells $990k in shares — Investing.com.
🤖 The article reports a director’s share sales, a backward-looking insider transaction rather than a company operating catalyst. The filing alone does not establish a directional outlook for the stock.
🍭 Bonus (B): 0/10 — Catalog & Mail-Order

DGII 📌 MONITOR - Digi International Inc.
Score: 64/100 (44+0+10+10) Price: $75.21 Chg: +3.0% RSI: 53 Vol: 379K 3yr High: $85.24

🏢 What they do: Digi International Inc. (DGII) is an Industrial Internet of Things (IIoT) technology company that provides cellular routers, gateways, embedded system-on-modules (SOMs), single-board computers (SBCs), RF modules, and sensor-based solutions for connecting devices in demanding environments.
- 🎯 Current $75.21 is 12% below 3yr high $85.24 · ⏳ SMA200 $60.06 (current price $75.21 is above) · 💰 Market Cap $2.8B
- DGII shows decent technicals supported by positive sentiment.

💎 Quality (Q): 44/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 48% (>20%); Low LT D/E 0.16 (<1.0); PEG ratio 1.24 (<1.5).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 53 in healthy mid-range
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×3).
✅ Digi International launches EX60 enterprise 5G router — Investing.com.
🤖 Digi launched an enterprise 5G router for branch offices and distributed businesses, available through its sales channels as part of a hardware-and-services subscription. The product expands its cellular portfolio and could support sales growth.
✅ Digi International Announces Intent to Acquire Disruptive Technologies to Advance SmartSense Physical-World Intelligence Platform and Enter Europe — Yahoo Finance.
🤖 Digi agreed to acquire Disruptive Technologies for $130 million in cash, adding sensing technology and an established European customer base to SmartSense. The deal offers expansion opportunities, though it remains subject to regulatory approval and will be financed with Digi’s revolving credit facility.
✅ Opengear Expands Reach Through Pan-European Distribution Agreement with Ingram Micro — Business Wire.
🤖 Opengear, a Digi International company, signed its first pan-European distribution agreement with Ingram Micro. The agreement could broaden access to Opengear products across participating European markets.
🍭 Bonus (B): 10/10 — Computer Communications Equipment (Technology sector)

SMCI 📌 MONITOR - Super Micro Computer, Inc.
Score: 63/100 (49+0+4+10) Price: $44.94 Chg: +5.5% RSI: 65 Vol: 40.3M 3yr High: $117.86

🏢 What they do: Super Micro Computer (SMCI) designs and sells high-performance, energy-efficient servers, storage systems, and related hardware for data centers, cloud computing, enterprise IT, AI, and edge computing. It also provides server management software and integration/support services to help customers build and manage scalable computing infrastructure.
- 🎯 Current $44.94 is 62% below 3yr high $117.86 · ⏳ SMA200 $32.16 (current price $44.94 is above) · 💰 Market Cap $29.5B
- SMCI shows favorable technicals but negative sentiment warrants caution.

💎 Quality (Q): 49/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 409% (>20%); Revenue growth 93% (>15%); ROE 15% (>15%); Low LT D/E 0.01 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (9.3%)
- 🔔 Strong above EMA50 (17.7%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 4/10
- 🗞️ News sentiment is negative (❌×1 ⚪️×4; showing 3 of 5).
❌ Jim Cramer Says He Prefers This “Monster” Stock Over ... — Yahoo Finance.
🤖 The article highlights strong AI orders and a record backlog, but also reports weak fiscal-year gross margins, sharply negative operating cash flow, and rising inventory and receivables. Those financial pressures temper the growth outlook.
⚪️ Super Micro Computer (NASDAQ:SMCI) Stock Jumps 3.4% ... — MarketBeat.
🤖 The article reports an analyst upgrade and a 3.4% share-price rise, but the search result does not identify the upgrading analyst or provide enough detail to assess the rating change. It also notes that quarterly EPS beat estimates while revenue missed them.
⚪️ Why Is Super Micro Computer Stock Trading Higher Today? — Benzinga.
🤖 SMCI shares rose about 2%, but the reported catalyst was a funding round for AI infrastructure provider Lambda, not a company-specific development at Super Micro. The article also mentions SMCI’s AI demand and product launches without reporting a new catalyst.
🍭 Bonus (B): 10/10 — Electronic Computers (Technology sector)

🔍 Screening Criteria Changelog →

Back to top ↑

🌱 ESG/SRI Exclusions

The following categories are excluded from our screening universe (with a few whitelisted exceptions):

Back to top ↑

Get Daily Advanced Signals Free

Actionable and freshly screened US 🇺🇸 stocks in your inbox every trading day.

Your subscription could not be saved. Please try again.
Your subscription has been successful.